Government Affairs
Refine Search
Pharmaceutical
The outgoing chief executive of under-siege Canadian drugmaker Valeant Pharmaceuticals will be grilled by a US Senate panel over rising drug prices. 29 March 2016
Pharmaceutical
The Russian Parliament (State Duma) will consider a draft of a new federal law that will establish a state monopoly on the production of drugs in Russia, reports The Pharma Letter’s local correspondent. 24 March 2016
Pharmaceutical
In the next five years, where is China’s pharma industry heading to? How should pharma companies allocate their resources to ensure the reward? The answers lie in the recently released guidance for the pharma industry five-year development from China’s top authority – the State Council, reports The Pharma Letter’s local correspondent Wang Fangqing. 22 March 2016
Pharmaceutical
The UK government has committed to renegotiate its membership of the European Union and to giving the UK electorate the chance, in a referendum, to choose between the revised membership terms or “Brexit.” 17 March 2016
Pharmaceutical
Stephen Ubl, president and chief executive of the Pharmaceutical Research and Manufacturers of America (PhRMA), is optimistic that the association’s series of policy proposals can help to prompt a bright new period in drug discovery. 15 March 2016
Pharmaceutical
Global drugmakers operating in Russia may totally refuse to supply imports of cheap drugs to the country, due to unprofitability and economic futility, according to recent statements of Veronika Skvortsova, Russia’s Ministry of Health. 14 March 2016
Pharmaceutical
The Indian government will not take any decision on drug price control without holding discussions with the pharmaceutical industry and other stakeholders, Union Minister of State for Chemicals and Fertilisers, Hansraj Gangaram Ahir, said at an ASSOCHAM (The Associated Chambers of Commerce & Industry of India) event held in New Delhi today. 10 March 2016
Pharmaceutical
The USA’s Office of the Assistant Secretary for Planning and Evaluation (ASPE) this week released its Observations on trends in prescription drug spending, noting that expenditures on Rx medicines are rising and are projected to continue to rise faster than overall health spending thereby increasing this sector’s share of health care spending. 9 March 2016
Pharmaceutical
The US Centers for Medicare & Medicaid Services (CMS) has announced a proposed rule to test new models to improve how Medicare Part B pays for prescription drugs and supports physicians and other clinicians in delivering higher quality care. 9 March 2016
Pharmaceutical
The pharma industry has paid the UK's Department of Health more than £1 billion ($1.42 billion) towards the cost of new medicines, figures published on Wednesday by the Association of the British Pharmaceutical Industry (ABPI) show. 9 March 2016
Pharmaceutical
Denmark’s pharmaceutical industry is going head-to-head with its Swedish counterpart by arguing Denmark should be the new home of the European Medicines Agency (EMA) if Britain votes to leave the European Union in the June 23 referendum, according to a report by EurActive. 5 March 2016
Pharmaceutical
US Senator Ted Cruz wants to change the way the Food and Drug Administration approves drugs. Indeed, the introduction of his “Reciprocity Ensures Streamlined Use of Lifesaving Treatments (RESULT) Act” has sparked hot debate, says Dr Nicola Davies in her monthly FDA Blog for The Pharma Letter. 29 February 2016
Pharmaceutical
A private member’s bill that would help doctors in the UK try innovative treatments on patients has moved forward another step in the Parliamentary process. 26 February 2016
Pharmaceutical
Bayer’s outgoing chief executive Marijn Dekkers has made an impassioned plea to governments in Europe to start taking serious measures to encourage innovation. 25 February 2016
Pharmaceutical
Australia’s Parliament has today passed the Turnbull Government’s historic legislation delivering the “missing piece” for Australian patients and their doctors to access a safe, legal and reliable supply of medicinal cannabis products for the management of painful and chronic conditions. 24 February 2016
Generics
The balance between incentivizing drug developers to make innovative drugs and providing affordable treatment is no mean feat. Many governments, including in the US, publically assert the importance of striking such a balance. 22 February 2016
Pharmaceutical
The Korean Medical Association declared that unethical business practices regarding drug supplies are not occurring from the ethical issues with doctors, but from the problems in the system itself. 22 February 2016
Pharmaceutical
Claims have been made that, in order for South Korea to become a new drug powerhouse of a global scale, the unreasonable price setting system for new drugs must be improved first, reports the local Munhwa Ilbo newspaper, which has been posted on the website of trade group KRPIA, which represents the research-based pharmaceutical industry. 15 February 2016
Pharmaceutical
Commenting on US President Barack Obama’s Budget speech yesterday, Pharmaceutical and Research Manufacturers of America (PHRMA) says that the biopharmaceutical industry is committed to advancing solutions for a competitive, value-based health care system that makes better use of today’s medicines and fosters the development of tomorrow’s cures. 10 February 2016
Pharmaceutical
Ukraine’s Association of Pharmaceutical Research and Development (APRaD) representatives recently took part in a meeting with Igor Perehinets, Deputy Minister of Health of Ukraine devoted to the health care reform and public procurements in the health care sector. 8 February 2016
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze